The Striking Difference Between States That Expanded Medicaid and the Ones That Didn’t

The number of Americans without health insurance declined to 9.1 percent last year, according to federal data released Tuesday. A set of maps released by the Census Bureau suggests an obvious way to decrease the uninsured rate even more: expand Medicaid in the 19 states that haven't.

Read More

GOP Report: State-Run ObamaCare Exchanges Are Headed For Collapse

The dozen ObamaCare exchanges run by the states are struggling financially and could be headed toward collapse over the next several years, according to a new report released Tuesday by House Republicans.

Read More

Humana Will Reduce Its Public Exchange Presence by Nearly 90% in 2017

Early in August commercial health insurer Humana Inc. disclosed it was joining a growing list of big insurance companies scaling back participation in public health exchanges.

Read More

Behind The EpiPen Monopoly: Lobbying, Flailing Competition And Tragedy

Thirteen year-old Natalie Giorgi probably didn’t know the name of the company that makes EpiPen. The 2013 death of the Sacramento girl from a peanut-induced allergy attack inspired passage of the California law that made the Mylan product a staple at every school.

Read More

Drug Industry Group Starts Ad Campaign to Defend Pricing

A top pharmaceutical lobbying group is launching an ad campaign to defend drugmakers that have been under fire for their pricing practices.

Read More

How Kaiser Permanente Aims to Boost the ‘Cool’ Factor in Health

Patients are behaving more like consumers when it comes to healthcare, which presents a unique opportunity to make health “cooler,” according to Kaiser Permanente CEO Bernard Tyson.

Read More

A Scary Obamacare Mystery

Pop quiz: Are the Obamacare exchanges a success? Your answer should take into account three recent pieces of news about the online marketplaces created by the Affordable Care Act:

Read More

A Push to Lower Drug Prices That Hit Insurers and Employers the Hardest

Americans have expressed outrage at drug companies for raising prices on products like EpiPen, the severe allergy treatment needed by thousands of children, and Daraprim, a rarely used but essential drug to treat a parasitic infection.

Read More

People Slammed by Medical Bills

People struck by surprise medical bills are easy to find.

Read More

Lobbyists Prepare for Clinton Win

In late summer, after the Democratic National Convention ended, a powerful trade group in Washington had a message for its industry: Hillary Clinton, at that moment, was likely to win the White House.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square